Liverpool High School, ESF, and Upstate Medical graduate, Dr. Mike Curtis, has made history as CEO of eGenesis, with the successful transplantation of the first pig kidney into a living human. This groundbreaking achievement is the result of decades of research in organ reduction technology, genome engineering, cloning, and immune suppression.
The implications of this advancement are immense, offering hope to thousands of people on the kidney transplant waitlist, on dialysis, and those with renal failure. The success of this procedure could bring much-needed attention to the field of organ transplantation and provide new options for those who have exhausted traditional treatments.
In addition to kidney transplants, eGenesis is working on programs for treating acute liver failure and heart transplants using porcine organs. This technology has the potential to revolutionize the field of organ transplantation and provide a sustainable and compatible supply of organs to meet the demand for transplant patients.
By offering a new source of organs for transplantation, eGenesis is paving the way for saving many lives in need of new organs. This breakthrough has the potential to change the lives of countless individuals and push the boundaries of what is possible in the field of medicine.
“Infuriatingly humble tv expert. Friendly student. Travel fanatic. Bacon fan. Unable to type with boxing gloves on.”